Nordion International and Bioaxone Biosciences Reach an Agreement to Settle Claims

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OTTAWA, Canada--(BUSINESS WIRE)--Nordion Inc. (TSX:NDN) (NYSE:NDZ) has reached an agreement to settle claims filed against Nordion and its subsidiaries by BioAxone BioSciences, Inc. (“BioAxone”) for a nominal amount. The parties are finalizing the settlement documents, which are expected to be confidential.

Help employers find you! Check out all the jobs and post your resume.

Back to news